Phathom Pharmaceuticals (PHAT) Payables (2022 - 2025)
Historic Payables for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $1.1 million.
- Phathom Pharmaceuticals' Payables fell 8492.92% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 8492.92%. This contributed to the annual value of $10.5 million for FY2024, which is 1661.77% down from last year.
- As of Q3 2025, Phathom Pharmaceuticals' Payables stood at $1.1 million, which was down 8492.92% from $4.0 million recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Payables registered a high of $12.6 million during Q4 2023, and its lowest value of $1.1 million during Q3 2025.
- Its 4-year average for Payables is $6.9 million, with a median of $7.1 million in 2024.
- In the last 5 years, Phathom Pharmaceuticals' Payables surged by 8342.12% in 2024 and then crashed by 8492.92% in 2025.
- Phathom Pharmaceuticals' Payables (Quarter) stood at $10.0 million in 2022, then grew by 26.05% to $12.6 million in 2023, then decreased by 16.62% to $10.5 million in 2024, then crashed by 89.77% to $1.1 million in 2025.
- Its Payables was $1.1 million in Q3 2025, compared to $4.0 million in Q2 2025 and $11.6 million in Q1 2025.